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Disseminated Strongyloides Stercoralis mid Aspergillus Fumigatus
Presenting as Diffuse Interstitial Pneumonitis in a Steroid-Dependent
Chronic Obstructive Pulmonary Disease Patient
Larry Tankanow, MD,* and Michael S. Eichenhorn, MD^

We describe a patient with long-standing steroid-dependent chronic obstructive pulmonary disease
who was admitted with new diffuse interstitial pulmonary infiltrates. Strongyloides stercoralis was
present in the sputum and stool and responded to treatment. However, complicating disseminating
Aspergillus fumigatus infection eventuated in the patient's death. Strongyloides stercoralis infection
should be considered in patients with relevant exposure history, and complicating fungal and gramnegative bacterial infections which such patients may develop should be suspected. (Henry Ford Hosp
MedJ 1988;36:41-3)

S

trongyloides stercoralis is a parasitic nematode which has
been associated in the deaths of patients with a variety of
clinical disorders. It can persist for years without symptoms in a
nonnal host and occasionally progresses to dissemination with
resultant high mortality rates. Because the diagnosis of disseminated Strongyloides stercoralis is often made at autopsy, its
presence should be suspected in patients with altered immunity
who have a relevant exposure history. Secondary infections due
to gram-negative enteric bacteria or opportunistic fungal disease
can be a serious complication of this syndrome. We describe a
patient with both disseminated Strongyloides stercoralis and invasive Aspergillus fumigatus.

Case Report
A 59-year-old man with a known history of steroid-dependent
chronic obstmctive lung disease and alcohol abuse was transferred to
Henry Ford Hospital with hematuria, hemoptysis, hematemesis, and
respiratory failure requiring mechanical ventilation. He had been hospitalized on multiple occasions for exacerbations of chronic obstructive
lung di.sease during the two years before admission to our institution.
Treatment consisted of aminophylline, beta agonist inhalers, and
corticosteroids with response in each occasion. Priorto admission, the
prednisone dose was 40 mg/day for four months. His medical history
was remarkable for chronic atrial fibrillation, arteriosclerotic cardiovascular disease, and prostatic carcinoma surgically treated by
transurethral resection ofthe prostate at age 45.
In his youth he lived in Kentucky and as an adult had visited family
members there on at least two occasions, with his last visit 12 years
prior to admission to the hospital. He lived in Michigan most of his life.
His blood pressure was 138/86 mm Hg, pulse was 110 and irregular,
and temperature was 38.8°C. Other pertinent physical findings
included petechiae on the anterior and posterior thorax, abdomen,
left thigh, and fingers. Expiratory wheezing and bibasilar crackles
were noted on auscultation ofthe lungs. Although he was lethargic,
his neurologic examination was normal. The patient was mechanically ventilated.
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Laboratory findings on admission included a hematocrit of 35.4%,
hemoglobin 10.5 g%, and WBC count of 9,800/|xL with 82% neutrophils, 16% lymphocytes, and 2% monocytes. Gross hematuria and
hemoccult-positive stools were present. Cutaneous anergy was noted.
The chest roentgenogram demonstrated newly developed bilateral
interstitial changes not present on previous chest x-ray one month prior
to admission.
Although the initial diagnostic considerations centered around collagen vascular disease, a routine examination of blood-streaked sputum
demonstrated larvae of Strongyloides stercoralis (Figs 1 and 2). Subsequently, larvae were also identified in the stool.
Treatment with thiabendazole, 25 mg/kg twice daily for three weeks,
led to eradication of the larval forms from both sputum and stool, but
the patient remained febrile. Treatment for Enterobacter clocae and
Klebsiella pneumoniae idenufied in subsequent sputum analyses also
failed to provide clinical improvement. On two occasions, rare colonies
oi Aspergillus fumigatus were isolated from the sputum, but urine and
blood cultures repetitively failed to demonstrate this or other organisms. Despite ventilatory and hemodynamic support, the patient gradually deteriorated and died after 112 days of hospital ization. Postmortem
examination (Fig 3) demonstrated di\s?,e.mm!AQA Aspergillus fumigatus
with necrotizing bronchopneumonia, renal abscesses, purulent leptomeningitis, panencephalitis, and multiple necrotizing lesions in the
myocardium, epicardium, and endocardium.

Discussion
Strongyloides stercoralis is an intestinal nematode that affects
humans and is capable of causing autoinfection. Patients with
chronic infection with Strongyloides stercoralis are usually
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Fig 1—Gram stain of sputum showing larvae o/Strongyloides stercoralis.

Fig 2—Close-up o/ Strongyloides stercoralis larvae.
asymptomatic. However, severe abdominal pain, diarrhea, shock,
cough, fever, cerebral signs, and bacteremia have been reported
with disseminated strongyloidiasis (1-5). Patients atriskfor developing disseminated disease include those with protein calorie malnutrition, underlying hematological malignancies, achlorhydria,
alcoholism, and the immunocompromised host receiving corticosteroids or cytotoxic agents (1,3,6,7). In intemal autoinfection,
the rhabditiform larvae change into the filariform larvae in the intestinal tract and penetrate the mucosa of thefleumand colon entering
the portal circulation, with eventual circulation to and penetration
into the alveolar space. Strongyloides stercoralis has a worldwide
distribution and is endemic in certain areas of the United States,
particularly in eastern Kentucky, Tennessee, and other parts of
southem Appalachia (8). Some patients have developed disseminated disease years after presumptive exposure. At presentation,
patients with disseminated strongyloidiasis may present with vary-
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ing symptoms including abdominal pain, cough, shortness of
breath, hemoptysis, hematochezia, and respiratory insufficiency.
Invasive pulmonary aspergillosis (IPA) is also a serious systemic infection which can be diagnosed in the compromised
host. The vast majority of IPA cases occur in patients with hematologic malignancies, especially during induction or maintenance chemotherapy for acute nonlymphocytic leukemia (9,
10). Recipients of cardiac and renal transplants are also at an
increased risk (10-12). Patients with IPA usually show the following predisposing factors: 1) high-dose corticosteroids,
2) cytotoxic chemotherapy, or 3) leukopenia (9).
Physical findings in IPA are nonspecific and may consist of
fever, cough, hemoptysis, rales, and wheezing. Extrapulmonary dissemination occurs in 10% to 25% of patients with invasive aspergillosis (9,10,13). Aspergillus has been recovered from
sputum in less than 10% of patients with dissemination, and rou-

Strongyloidiasis and Aspergillosis Complicating COPD—Tankanow & Eichenhorn

Fig 3—Tissue imprint showing Aspergillus fumigatus demonstrated postmortem.
tine laboratory tests are usually not helpful in establishing a diagnosis (14). The definitive diagnosis of IPA is established by
demonstrating parenchymal invasion; thus bronchial washings
or bmshings that are cultured positive for Aspergillus can be interpretive only as presumptive evidence of IPA. The definitive
diagnosis of IPA is made by lung biopsy. Since IPA (as wefl as
disseminated aspergillosis) is a difficult diagnosis to establish
without tissue biopsy, serological studies may aid in establishing a diagnosis. The standard Aspergillus precipitin assay, often
strongly positive in allergic bronchopulmonary aspergillosis
and pulmonary aspergilloma, is generally undetectable or in low
titers in IPA. Serum precipitin as determined by counterimmunoelectrophoresis enzyme-linked immunoabsorbent assays have been reported to be positive in 70% to 80% of patients
with IPA (13,15), but the specificity of these assays is relatively
low (16).
Any patient with a relevant exposure history to Strongyloides
stercoralis and unexplained bacteremia should be carefully
screened for the parasite. Multiple sputum and stool samples as
well as proximal jejunal and duodenal aspirates may be required
to establish a diagnosis (17). Additionally, patients from endemic areas should be screened before starting any immunosuppressive therapy. Since secondary infections are common in
patients with an established diagnosis of disseminated Strongyloides (18), a thorough search for secondary infections due to
either enteric bacteria or opportunistic fungal infection should
be undertaken.
Our patient was presumably exposed to Strongyloides stercoralis while living in an endemic area as a child and probably
suffered from a chronic form of the disease until he was treated
with corticosteroids for obstructive lung disease. In addition, he
suffered from alcoholism and had a known history of prostatic
carcinoma. Once immunocompromised, he became an opportunistic host for both the disseminated Strongyloides stercoralis
and disseminated aspergillosis. Both are unusual infections
which carry a high mortality rate if not recognized early.
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